Vivo Bio Tech Secures 10.75 Crores Pre-Clinical Testing Contract for Novel Molecule Collaboration

Vivo Bio Tech Ltd has secured a major pre-clinical testing contract valued at 10.75 Crores for a novel molecule in collaboration with a leading organization. The contract, which includes toxicity studies, mutagenicity evaluations, ecotoxicology studies, and comprehensive analytical services, will last up to 2 years. This partnership strengthens Vivo Bio Tech's position as a trusted preclinical partner and reinforces its scientific and technical excellence in the global life sciences industry.